Status:
RECRUITING
Topical Sevoflurane for Treatment of Chronic Leg Ulcers
Lead Sponsor:
Charles University, Czech Republic
Collaborating Sponsors:
Faculty Hospital Kralovske Vinohrady
Conditions:
Leg Ulcer
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Patients with painful non-healing leg ulcer will be enrolled in the clinical single-blinded randomized study. The active treatment group will have sevoflurane applied at approximately 1 ml/cm2 at the ...
Detailed Description
A prospective single-blinded randomized study will be conducted in patients of the Dermatovenereology Clinic of the 3rd Medical Faculty of Charles University (3LF UK) and the University Hospital Kralo...
Eligibility Criteria
Inclusion
- Patients with painful (pain intensity on the numerical scale NRS 0-10 is NRS\>4) non- healing tibial venous ulcers
Exclusion
- Allergy to sevoflurane
- Inability to understand the pain-intensity questionnaire
Key Trial Info
Start Date :
May 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05303805
Start Date
May 2 2022
End Date
January 31 2027
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty Hospital Kralovske Vinohrady
Prague, Czechia, 100 00